Skip to main content
. 2021 May 5;8(13):2004685. doi: 10.1002/advs.202004685

Figure 8.

Figure 8

Antiviral applications of type VI CRISPR‐Cas systems. Programmed to target evolutionarily conserved genomic regions of ssRNA viruses or RNA intermediates of DNA viruses, type VI CRISPR‐Cas systems can be used to suppress viral infections in humans and animals, or to develop virus‐resistant crops and transgenic mosquitoes with reduced capacity for spreading viral diseases.